drug · Product Intelligence

Modafinil
Pipeline Intelligence

Modafinil: 7 indexed trials, 7 sponsors; 0 linked Orange Book patents and 10 FDA-linked events where matched.

⚗
7Indexed trials
▦
7Sponsors
⌁
0Orange Book patent links
◎
10FDA-linked events

Development evidence

NCT00102284University Hospital Muenster · other_neurologyPHASE4
NCT00215176Duke University · depressionPHASE2, PHASE3
NCT00315276Cephalon · adhdPHASE2
NCT01684306Università degli Studi 'G. d'Annunzio' Chieti e Pescara · other_neurologyEARLY_PHASE1
NCT01800097Herlev Hospital · strokePHASE3
NCT02857244University of Chicago · parkinsonsPHASE2
NCT05675098Kuwait University · cerebral_palsyEARLY_PHASE1

FDA / patent evidence

Orange Book match found; no listed patent relation was retained for this product match.

Regulatory context

FDA_APPROVALMODAFINIL · 2026-09-03
FDA_APPROVALMODAFINIL · 2017-09-14
FDA_APPROVALMODAFINIL · 2017-08-16
FDA_APPROVALMODAFINIL · 2014-02-03
FDA_APPROVALMODAFINIL · 2012-11-01
FDA_APPROVALMODAFINIL · 2012-09-27
FDA_APPROVALMODAFINIL · 2012-09-26
FDA_APPROVALMODAFINIL · 2012-09-26
FDA_APPROVALMODAFINIL · 2012-07-16
FDA_APPROVALPROVIGIL · 1998-12-24

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.